Mono Pharmacare to Consider H1'27 Financial Results on 14th Nov'26
Mono Pharmacare Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
Mono Pharmacare to Consider H1'27 Financial Results on 14th Nov'26 Mono Pharmacare Limited has scheduled a meeting of its Board of Directors on 14th Nov'26. The key agenda involves considering and approving the standalone and consolidated unaudited financial results, along with the statutory auditor's limited review report, for the half-year ended 30th Sep'26.
Original exchange filing (PDF)
More announcements from Mono Pharmacare Ltd
- MONOPHARMA : 21-Nov-2026 : The Company has informed the Exchange that a Board meeting to be held on November 14, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 21, 2026, To consider and approve the financial results for the period ended September 30, 2026 路 21 Nov 2026
- Mono Pharmacare Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 14 Nov 2026
- Mono Pharmacare Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q2 FY 2026-27 路 27 Oct 2026
- Integrated filing governance for quarter 2 2026-27 路 27 Oct 2026
- Integrated filing governance for quarter 1 2026-27 路 15 Oct 2026
- Mono Pharmacare Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q1 FY 2026-27 路 15 Oct 2026
- Mono Pharmacare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results. 路 02 Oct 2026
- Mono Pharmacare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026 路 30 Sept 2026
